BMJ. 2012 Sep 27;345:e6077. doi: 10.1136/bmj.e6077.
Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies.
BMJ (Clinical research ed.)
Jorine Verhaegen, Ioannis D Gallos, Norah M van Mello, Mohamed Abdel-Aziz, Yemisi Takwoingi, Hoda Harb, Jonathan J Deeks, Ben W J Mol, Arri Coomarasamy
Affiliations
Affiliations
- Department of Obstetrics and Gynaecology, Academic Medical Centre University of Amsterdam, Amsterdam, Netherlands.
PMID: 23045257
PMCID: PMC3460254 DOI: 10.1136/bmj.e6077
Abstract
OBJECTIVE: To determine the accuracy with which a single progesterone measurement in early pregnancy discriminates between viable and non-viable pregnancy.
DESIGN: Systematic review and meta-analysis of diagnostic accuracy studies.
DATA SOURCES: Medline, Embase, CINAHL, Web of Science, ProQuest, Conference Proceedings Citation Index, and the Cochrane Library from inception until April 2012, plus reference lists of relevant studies.
STUDY SELECTION: Studies were selected on the basis of participants (women with spontaneous pregnancy of less than 14 weeks of gestation); test (single serum progesterone measurement); outcome (viable intrauterine pregnancy, miscarriage, or ectopic pregnancy) diagnosed on the basis of combinations of pregnancy test, ultrasound scan, laparoscopy, and histological examination; design (cohort studies of test accuracy); and sufficient data being reported.
RESULTS: 26 cohort studies, including 9436 pregnant women, were included, consisting of 7 studies in women with symptoms and inconclusive ultrasound assessment and 19 studies in women with symptoms alone. Among women with symptoms and inconclusive ultrasound assessments, the progesterone test (5 studies with 1998 participants and cut-off values from 3.2 to 6 ng/mL) predicted a non-viable pregnancy with pooled sensitivity of 74.6% (95% confidence interval 50.6% to 89.4%), specificity of 98.4% (90.9% to 99.7%), positive likelihood ratio of 45 (7.1 to 289), and negative likelihood ratio of 0.26 (0.12 to 0.57). The median prevalence of a non-viable pregnancy was 73.2%, and the probability of a non-viable pregnancy was raised to 99.2% if the progesterone was low. For women with symptoms alone, the progesterone test had a higher specificity when a threshold of 10 ng/mL was used (9 studies with 4689 participants) and predicted a non-viable pregnancy with pooled sensitivity of 66.5% (53.6% to 77.4%), specificity of 96.3% (91.1% to 98.5%), positive likelihood ratio of 18 (7.2 to 45), and negative likelihood ratio of 0.35 (0.24 to 0.50). The probability of a non-viable pregnancy was raised from 62.9% to 96.8%.
CONCLUSION: A single progesterone measurement for women in early pregnancy presenting with bleeding or pain and inconclusive ultrasound assessments can rule out a viable pregnancy.
References
- BMC Med Res Methodol. 2009 Nov 10;9:73 - PubMed
- Fertil Steril. 1987 Dec;48(6):1048-50 - PubMed
- Med Decis Making. 2000 Oct-Dec;20(4):430-9 - PubMed
- J Clin Endocrinol Metab. 2007 May;92(5):1748-53 - PubMed
- Biometrics. 2003 Dec;59(4):936-46 - PubMed
- Hum Reprod. 1989 Apr;4(3):331-4 - PubMed
- Br J Hosp Med. 1997 Nov 19-Dec 9;58(10):505-9 - PubMed
- Obstet Gynecol. 1981 Aug;58(2):162-6 - PubMed
- Ultrasound Obstet Gynecol. 2003 Oct;22(4):420-30 - PubMed
- Eur J Obstet Gynecol Reprod Biol. 2003 Aug 15;109(2):181-4 - PubMed
- Fertil Steril. 2000 Mar;73(3):499-504 - PubMed
- Fertil Steril. 1996 Oct;66(4):513-6 - PubMed
- Am J Emerg Med. 2002 Nov;20(7):575-9 - PubMed
- Fertil Steril. 1991 Mar;55(3):492-6 - PubMed
- Am J Obstet Gynecol. 1987 Mar;156(3):669-74 - PubMed
- Obstet Gynecol. 1993 May;81(5 ( Pt 1)):705-9 - PubMed
- Fertil Steril. 1999 Oct;72(4):643-5 - PubMed
- Gynecol Obstet Invest. 1992;34(3):133-8 - PubMed
- Aust N Z J Obstet Gynaecol. 1996 Aug;36(3):319-23 - PubMed
- Ultrasound Obstet Gynecol. 2009 Jun;33(6):704-10 - PubMed
- Ultrasound Obstet Gynecol. 1999 Oct;14(4):231-6 - PubMed
- Acad Emerg Med. 1998 Apr;5(4):309-13 - PubMed
- Z Geburtshilfe Perinatol. 1988 May-Jun;192(3):130-2 - PubMed
- BMJ. 1997 Jul 5;315(7099):32-4 - PubMed
- J Obstet Gynaecol. 2008 May;28(4):413-7 - PubMed
- Fertil Steril. 1991 Mar;55(3):497-500 - PubMed
- Lancet. 2000 Nov 25;356(9244):1844-7 - PubMed
- Am J Obstet Gynecol. 1992 Feb;166(2):562-6 - PubMed
- Fertil Steril. 1990 Jun;53(6):1029-36 - PubMed
- J Clin Epidemiol. 2004 Sep;57(9):925-32 - PubMed
- Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1497-502 - PubMed
- Ann Emerg Med. 2000 Aug;36(2):95-100 - PubMed
- J Fla Med Assoc. 1992 Apr;79(4):237-9 - PubMed
- BMC Med Res Methodol. 2003 Nov 10;3:25 - PubMed
- Acad Emerg Med. 1998 Apr;5(4):304-9 - PubMed
- Stat Med. 2001 Oct 15;20(19):2865-84 - PubMed
- Hum Reprod. 1998 Nov;13(11):3220-7 - PubMed
Substances
MeSH terms
Publication Types